Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
Naproxen 250mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to off white circular flat faced bevelled edge, uncoated tablet with inscription ‘AP’ on one side and breakline on the other side. |
Each tablet contains 250 mg naproxen.
Excipient with known effect: Lactose monohydrate.
Each tablet contains 72 mg of lactose monohydrate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Naproxen |
Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. |
| List of Excipients |
|---|
|
Lactose monohydrate |
White polypropylene containers with LDPE closure having tamper evident seal: 1000, 500, 250, 100, 84,70, 56,42, 28, 21, 15 and 14 tablets.
Blister Strips (composed of PVC film and aluminium foil): 84, 70, 56, 42, 28, 21, 15 and 14 tablets.
Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
PL 20075-0058
03/09/2007
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
